AP
XLRN
AlpInvest Partners’s Acceleron Pharma Inc. XLRN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | – | Hold |
0
| – | – | – | 11 |
|
|
2017
Q2 | – | Sell |
-21,106
| Closed | -$559K | – | 9 |
|
|
2017
Q1 | $559K | Sell |
21,106
-2,166
| -9% | -$57.4K | 1.73% | 13 |
|
|
2016
Q4 | $594K | Buy |
23,272
+13,921
| +149% | +$355K | 2.1% | 12 |
|
|
2016
Q3 | $338K | Hold |
9,351
| – | – | 0.84% | 13 |
|
|
2016
Q2 | $318K | Hold |
9,351
| – | – | 0.63% | 23 |
|
|
2016
Q1 | $247K | Hold |
9,351
| – | – | 0.47% | 27 |
|
|
2015
Q4 | $456K | Sell |
9,351
-15,843
| -63% | -$773K | 0.76% | 23 |
|
|
2015
Q3 | $627K | Hold |
25,194
| – | – | 1.23% | 22 |
|
|
2015
Q2 | $797K | Buy |
25,194
+8,198
| +48% | +$259K | 1.01% | 19 |
|
|
2015
Q1 | $647K | Sell |
16,996
-4,607
| -21% | -$175K | 1.21% | 17 |
|
|
2014
Q4 | $842K | Buy |
+21,603
| New | +$842K | 2.09% | 9 |
|